EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antioxidant Properties of Zinc and Copper—Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers

Milena Matuszczak iD, Adam Kiljańczyk iD, Wojciech Marciniak iD, Róża Derkacz iD, Klaudia Stempa, Piotr Baszuk iD, Marta Bryśkiewicz, Cezary Cybulski, Tadeusz Dębniak iD, Jacek Gronwald iD, Tomasz Huzarski, Marcin Lener und 15 weitere

Antioxidants · 14.07.2024 · 13 (7) · 841

DOI: 10.3390/antiox13070841 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 14.07.2024. Verfasst von Milena Matuszczak und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, ul. Unii Lubelskiej 1, 71-252 Szczecin, …. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: program of Minister of Science and Higher Education"Regional Initiative of Excellence" in years 2019-2022, Science and Higher Education“Regional Initiative of Excellence” in years 2019–2022.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic mutations in BRCA1 (BReast CAncer gene 1) confer high risks of both breast (up to 70%) and ovarian (up to 40%) cancers. Zinc (Zn) and copper (Cu) are essential for various physiological functions, including antioxidant reactions. Their balance, reflected in the Zn/Cu ratio, plays a crucial role in maintaining redox homeostasis, which is vital for cancer prevention. This study examines the antioxidant properties of Zn and Cu, specifically focusing on the blood Zn/Cu ratio as a potential marker for cancer risk among BRCA1 mutation carriers. The study cohort consisted of 989 initially unaffected women, followed up for 7.5 years. Blood samples were analyzed using inductively coupled plasma mass spectrometry. Although individual Zn and Cu levels did not significantly correlate with overall cancer risk, those women with a Zn/Cu ratio above 6.38 experienced a significantly lower cancer risk than women with a ratio below this cut-off point. This suggests that the Zn/Cu ratio may be a valuable biomarker for cancer prevention in this high-risk group. Given the increased cancer risk in BRCA1 mutation carriers, optimizing Zn and Cu levels through dietary and active interventions could provide a preventive strategy.

Schlagwörter

Stichwörter der Autor:innen

BRCA1BRCA1 mutationblood levelsbreast cancercancer riskcoppergermline mutationmodifiersovarian cancerpropective cohortzinc

Autor:innen und Institutionen

  • Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, ul. Unii Lubelskiej 1, 71-252 Szczecin, Poland.
  • Read-Gene, Grzepnica, ul. Alabastrowa 8, 72-003 Dobra, Poland.
  • Department of Clinical Genetics and Pathology, University of Zielona Góra, ul. Zyty 28, 65-046 Zielona Góra, Poland.
  • Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland.
  • Department of Surgery and Oncology, University of Zielona Góra, Zyty 28, 65-046 Zielona Góra, Poland.
  • OPEN, Kazimierza Wielkiego 24 Str., 61-863 Poznań, Poland.

ORCID-Profile: Milena Matuszczak, Adam Kiljańczyk, Wojciech Marciniak, Róża Derkacz, Piotr Baszuk, Tadeusz Dębniak, Jacek Gronwald, Anna Jakubowska, Marek Szwiec, Małgorzata Stawicka-Niełacna, Andrzej Jasiewicz, Tomasz Kluz, Joanna Tomiczek-Szwiec, Rafał Wiśniowski, Rodney Scott, Jan Lubiński

Förderung

  • program of Minister of Science and Higher Education"Regional Initiative of Excellence" in years 2019-2022
  • Science and Higher Education“Regional Initiative of Excellence” in years 2019–2022

Zitieren

APA

Matuszczak, M., Kiljańczyk, A., Marciniak, W., Derkacz, R., Stempa, K., Baszuk, P., Bryśkiewicz, M., Cybulski, C., Dębniak, T., Gronwald, J., Huzarski, T., Lener, M., Jakubowska, A., Szwiec, M., Stawicka-Niełacna, M., Godlewski, D., Prusaczyk, A., Jasiewicz, A., Kluz, T., …, & Lubiński, J. (2024). Antioxidant Properties of Zinc and Copper—Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers. Antioxidants, 13(7), 841. https://doi.org/10.3390/antiox13070841

Vancouver

Matuszczak M, Kiljańczyk A, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al. Antioxidant Properties of Zinc and Copper—Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers. Antioxidants. 2024;13(7):841. doi:10.3390/antiox13070841

BibTeX
@article{Matuszczak2024,
  author = {Matuszczak, Milena and Kiljańczyk, Adam and Marciniak, Wojciech and Derkacz, Róża and Stempa, Klaudia and Baszuk, Piotr and Bryśkiewicz, Marta and Cybulski, Cezary and Dębniak, Tadeusz and Gronwald, Jacek and Huzarski, Tomasz and Lener, Marcin and Jakubowska, Anna and Szwiec, Marek and Stawicka-Niełacna, Małgorzata and Godlewski, Dariusz and Prusaczyk, Artur and Jasiewicz, Andrzej and Kluz, Tomasz and Tomiczek-Szwiec, Joanna and Kilar-Kobierzycka, Ewa and Siołek, Monika and Wiśniowski, Rafał and Posmyk, Renata and Jarkiewicz-Tretyn, Joanna and Scott, Rodney and Lubiński, Jan},
  title = {Antioxidant Properties of Zinc and Copper—Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers},
  journal = {Antioxidants},
  year = {2024},
  volume = {13},
  number = {7},
  pages = {841},
  doi = {10.3390/antiox13070841}
}
Kostenlos starten →